Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Ornitz

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1991
Binary system for regulating transgene expression in mice: targeting int-2 gene expression with yeast GAL4/UAS control elementsD M Ornitz, R W Moreadith, P Leder
Mechanisms of Development|January 21, 2000
Subcellular and developmental expression of alternatively spliced forms of fibroblast growth factor 14Q Wang, D G McEwen, D M Ornitz
Genomics|June 15, 1999
Mapping the mouse otoconin-90 (Oc90) gene to chromosome 15Y Wang, I Thalmann, R Thalmann, et al.
The Journal of Biological Chemistry|November 27, 1999
Mapping ligand binding domains in chimeric fibroblast growth factor receptor molecules. Multiple regions determine ligand binding specificityA Chellaiah, W Yuan, M Chellaiah, et al.
The Journal of Biological Chemistry|August 25, 1981
Nitrate reductase from Penicillium chrysogenum. Purification and kinetic mechanismF Renosto, D M Ornitz, D Peterson, et al.
Journal of the National Cancer Institute|June 3, 1992
Int-2, an autocrine and/or ultra-short-range effector in transgenic mammary tissue transplantsD M Ornitz, R D Cardiff, A Kuo, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 2000
Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndromeK Yu, A B Herr, G Waksman, et al.
Nature Genetics|June 1, 1996
Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasiaM C Naski, Q Wang, J Xu, et al.
Mechanisms of Development|June 25, 1999
Genomic structure, mapping, activity and expression of fibroblast growth factor 17J Xu, A Lawshe, C A MacArthur, et al.
Development (Cambridge, England)|October 5, 2001
Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domainsQ Wang, R P Green, G Zhao, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1991
Binary system for regulating transgene expression in mice: targeting int-2 gene expression with yeast GAL4/UAS control elementsD M Ornitz, R W Moreadith, P Leder
Mechanisms of Development|January 21, 2000
Subcellular and developmental expression of alternatively spliced forms of fibroblast growth factor 14Q Wang, D G McEwen, D M Ornitz
Genomics|June 15, 1999
Mapping the mouse otoconin-90 (Oc90) gene to chromosome 15Y Wang, I Thalmann, R Thalmann, et al.
The Journal of Biological Chemistry|November 27, 1999
Mapping ligand binding domains in chimeric fibroblast growth factor receptor molecules. Multiple regions determine ligand binding specificityA Chellaiah, W Yuan, M Chellaiah, et al.
The Journal of Biological Chemistry|August 25, 1981
Nitrate reductase from Penicillium chrysogenum. Purification and kinetic mechanismF Renosto, D M Ornitz, D Peterson, et al.
Journal of the National Cancer Institute|June 3, 1992
Int-2, an autocrine and/or ultra-short-range effector in transgenic mammary tissue transplantsD M Ornitz, R D Cardiff, A Kuo, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 2000
Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndromeK Yu, A B Herr, G Waksman, et al.
Nature Genetics|June 1, 1996
Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasiaM C Naski, Q Wang, J Xu, et al.
Mechanisms of Development|June 25, 1999
Genomic structure, mapping, activity and expression of fibroblast growth factor 17J Xu, A Lawshe, C A MacArthur, et al.
Development (Cambridge, England)|October 5, 2001
Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domainsQ Wang, R P Green, G Zhao, et al.
Pageof 7